Open Access Articles- Top Results for Lenograstim


Clinical data
Trade names Euprotin, Granocyte, Lenobio, Neutrogin
AHFS/ International Drug Names
135968-09-1 7pxN
UNII 6WS4C399GB 7pxY
Chemical data
 14pxN (what is this?)  (verify)

Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator.[1][2] It is developed by Chugai Pharmaceuticals under the brand name Granocyte.


  1. ^ "USAN Council. List No. 340. New names. Lenograstim". Clin. Pharmacol. Ther. 52 (1): 113. July 1992. PMID 1284891. 
  2. ^ Amadori S, Suciu S, Jehn U, Stasi R, Thomas X, Marie JP, Muus P, Lefrère F, Berneman Z, Fillet G, Denzlinger C, Willemze R, Leoni P, Leone G, Casini M, Ricciuti F, Vignetti M, Beeldens F, Mandelli F, De Witte T (July 2005). "Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study". Blood 106 (1): 27–34. PMC 1895135. PMID 15761020. doi:10.1182/blood-2004-09-3728. 

Lua error in package.lua at line 80: module 'Module:Buffer' not found.